Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection

被引:15
|
作者
Yuan, Yan [1 ,2 ]
Xiao, Wei-Wei [1 ,2 ]
Xie, Wei-Hao [1 ,2 ]
Cai, Pei-Qiang [1 ,3 ,4 ]
Wang, Qiao-Xuan [1 ,2 ]
Chang, Hui [1 ,2 ]
Chen, Bao-Qing [1 ,2 ]
Zhou, Wen-Hao [1 ,5 ]
Zeng, Zhi-Fan [1 ,2 ]
Wu, Xiao-Jun [1 ,5 ]
Liu, Qing [1 ,6 ]
Li, Li-Ren [1 ,5 ]
Zhang, Rong [1 ,7 ]
Gao, Yuan-Hong [1 ,2 ]
机构
[1] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Canc Ctr, Dept Med Imaging, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Canc Ctr, Dept Intervent Radiol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Ctr Canc, Dept Epidemiol & Biostat, Guangzhou, Peoples R China
[7] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy & Laser, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Locally advanced colon cancer; Neoadjuvant chemoradiotherapy; Organ preservation; Pathological complete response; ADVANCED RECTAL-CANCER; COLORECTAL-CANCER; CHEMOTHERAPY; SURGERY;
D O I
10.1186/s12885-021-07894-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe management of unresectable locally advanced colon cancer (LACC) remains controversial, as resection is not feasible. The goal of this study was to evaluate the treatment outcomes and toxicity of neoadjuvant chemoradiotherapy (NACRT) followed with surgery and adjuvant chemotherapy in patients with unresectable radically LACC.MethodsWe included patients who were diagnosed at our institution, 2010-2018. The neoadjuvant regimen consisted of radiotherapy and capecitabine/ 5-fluorouracil-based chemotherapy.ResultsOne hundred patients were identified. The median follow-up time was 32months. The R0 resection rate, adjusted nonmultivisceral resection rate and bladder preservation rate were 83.0, 43.0 and 83.3%, respectively. The pCR and clinical-downstaging rates were 18, and 81.0%%, respectively. The 3-year PFS and OS rates for all patients were 68.6 and 82.1%, respectively. Seventeen patients developed grade 3-4 myelosuppression, which was the most common adverse event observed after NACRT. Tumor perforation occurred in 3 patients during NACRT. The incidence of grade 3-4 surgery-related complications was 7.0%. Postoperative anastomotic leakage was observed in 3 patients.ConclusionsNACRT followed by surgery was feasible and safe for selected patients with LACC, and can be used as a conversion treatment to achieve satisfactory downstaging, long-term survival and quality of life, with acceptable toxicities.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy
    Sato, Sho
    Kunisaki, Chikara
    Suematsu, Hideaki
    Tanaka, Yusaku
    Miyamoto, Hiroshi
    Kosaka, Takashi
    Yukawa, Norio
    Tanaka, Kuniya
    Sato, Kei
    Akiyama, Hirotoshi
    Endo, Itaru
    IN VIVO, 2018, 32 (03): : 603 - 610
  • [42] Nutritional Status During Concurrent Chemoradiotherapy (CCRT) Is Critical for Survival in Patients with Locally Advanced Unresectable Esophageal Cancer
    Huang, T. T.
    Li, S. H.
    Lu, H. I.
    Chen, Y. H.
    Lo, C. M.
    Fang, F. M.
    Chou, S. Y.
    Chiu, Y. C.
    Chou, Y. P.
    Wang, Y. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E185 - E186
  • [43] Neoadjuvant Chemoradiotherapy Significantly Improved R0 Resection Rate in Unresectable Locally Advanced Colon Cancer: The Initial Analysis from the Randomized Controlled Phase 3 Trial
    Zhang, Z. T.
    Wu, J. X.
    Wang, Q. X.
    Huang, X. X.
    Tian, X.
    Chang, H.
    Zeng, Z.
    Xiao, W.
    Li, R. L.
    Gao, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E611 - E611
  • [44] Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer
    Chun-Ming Huang
    Ming-Yii Huang
    Cheng-Jen Ma
    Yung –Sung Yeh
    Hsiang-Lin Tsai
    Ching-Wen Huang
    Chih-Jen Huang
    Jaw-Yuan Wang
    Radiation Oncology, 12
  • [45] Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer
    Huang, Chun-Ming
    Huang, Ming-Yii
    Ma, Cheng-Jen
    Yeh, Yung-Sung
    Tsai, Hsiang-Lin
    Huang, Ching-Wen
    Huang, Chih-Jen
    Wang, Jaw-Yuan
    RADIATION ONCOLOGY, 2017, 12
  • [46] Extracapsular Extension Does Not Decrease Overall Survival in Rectal Cancer Patients with Lymph Node Metastasis Following Neoadjuvant Chemoradiotherapy
    Lino-Silva, Leonardo S.
    Sanchez-Acosta, Carmen I.
    Salcedo-Hernandez, Rosa A.
    Zepeda-Najar, Cesar
    GASTROENTEROLOGY INSIGHTS, 2020, 11 (02) : 11 - 19
  • [47] Prognostic Factors for Survival and Resection in Patients With Initial Nonresectable Locally Advanced Pancreatic Cancer Treated With Chemoradiotherapy
    Bjerregaard, Jon K.
    Mortensen, Michael B.
    Jensen, Helle A.
    Nielsen, Morten
    Pfeiffer, Per
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : 909 - 915
  • [48] Safety and feasibility of single-port laparoscopic multivisceral resection for locally advanced left colon cancer
    Tei, Mitsuyoshi
    Otsuka, Masahisa
    Suzuki, Yozo
    Kishi, Kentaro
    Tanemura, Masahiro
    Akamatsu, Hiroki
    ONCOLOGY LETTERS, 2018, 15 (06) : 10091 - 10097
  • [49] CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
    Tong, Yilin
    Zhao, Yan
    Shan, Zexing
    Zhang, Jianjun
    BMC CANCER, 2021, 21 (01)
  • [50] NEOADJUVANT RADIATION THERAPY IMPROVES SURVIVAL IN LOCALLY ADVANCED COLON CANCER.
    Krishnamurty, D. Mukkai
    Hawkins, A.
    Wells, K.
    Silviera, M.
    Mutch, M.
    Glasgow, S.
    Hunt, S.
    Dharmarajan, S.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E266 - E266